C15H18N4O5
Neat
334.33
Albomitomycin C; AD9LEA38ZF; 111750-67-5; Mitomycin impurity D [EP]; MITOMYCIN IMPURITY D [EP IMPURITY]; ((1S, 2S, 4aS, 8aR, 9S, 9aR)-7-Amino-9a-methoxy-6-methyl-5, 8-dioxo-1, 2, 3, 5, 8, 8a, 9, 9a-octahydro-1, 2, 4a-metheno-(epinitrilo)pyrrolo(1, 2-a)indol-9-yl)methyl carbamate; 1, 2, 5-Metheno-1H, 5H-imidazo(2, 1-i)indole-7, 10-dione, 8-amino-6-(((aminocarbonyl)oxy)methyl)-2, 3, 6, 6a-tetrahydro-5-methoxy-9-methyl-, (1S, 2S, 4S, 5R, 6S, 6aR, 10aS, 11S)-; 1, 2, 5-METHENO-1H, 5H-IMIDAZO(2, 1-I)INDOLE-7, 10-DIONE, 8-AMINO-6-(((AMINOCARBONYL)OXY)METHYL)-2, 3, 6, 6A-TETRAHYDRO-5-METHOXY-9-METHYL-, (1S-(1.ALPHA., 2.ALPHA., 4.BETA., 5.BETA., 6.ALPHA., 6A.ALPHA., 10AR*, 11R*))-; 1, 2, 5-Metheno-1H, 5H-imidazo(2, 1-i)indole-7, 10-dione, 8-amino-6-(((aminocarbonyl)oxy)methyl)-2, 3, 6, 6a-tetrahydro-5-methoxy-9-methyl-, (1S-(1alpha, 2alpha, 4beta, 5beta, 6alpha, 6aalpha, 10ar*, 11R*))-; MITOMYCIN IMPURITY D (EP IMPURITY); Mitomycin impurity D; RefChem:199411; ((1S, 2S, 4S, 4aS, 8aR, 9S, 9aR, 10S)-7-Amino-9a-methoxy-6-methyl-5, 8-dioxo-1, 2, 3, 5, 8, 8a, 9, 9a-octahydro-1, 2, 4a-(epinitrilo)pyrrolo[1, 2-a]indol-9-yl)methyl carbamate; starbld0039431; UNII-AD9LEA38ZF; SCHEMBL18067138; [(1S, 3S, 4S, 7R, 8S, 9R)-11-amino-7-methoxy-12-methyl-10, 13-dioxo-2, 6-diazapentacyclo[7.4.0.01, 6.02, 4.03 and 7]tridec-11-en-8-yl]methyl carbamate
[(1S, 3S, 4S, 7R, 8S, 9R)-11-amino-7-methoxy-12-methyl-10, 13-dioxo-2, 6-diazapentacyclo[7.4.0.01, 6.02, 4.03 and 7]tridec-11-en-8-yl]methyl carbamate
InChI=1S/C15H18N4O5/c1-5-9(16)10(20)8-6(4-24-13(17)22)15(23-2)11-7-3-18(15)14(8,12(5)21)19(7)11/h6-8,11H,3-4,16H2,1-2H3,(H2,17,22)/t6-,7+,8+,11+,14-,15-,19?/m1/s1